Patients with recurrent malignant ventricular arrhythmias - Therapeutic challenge

Michael Geist*, Yoseph Rozenman

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review


Patients with malignant refractory ventricular arrhythmias present a unique therapeutic challenge. In recent years, this challenge has become even more complex due to the wide spread use of implantable cardiac defibrillators. If, in the past, a majority of the patients succumbed due to these arrhythmias, today, due to the defibrillators, they survive and then need further treatment. The defibrillators treat the arrhythmias when they occur but in most cases do not prevent their initiation. In many cases we need to resort to other modalities. We present three patients who exemplify various options of dealing with this complex issue.

Original languageEnglish
Pages (from-to)348-349
Number of pages2
Issue number5 SPEC. ISS.
StatePublished - May 2006
Externally publishedYes


  • Defibrillators
  • Dofetilide
  • Radiofrequency ablation
  • VF
  • VT


Dive into the research topics of 'Patients with recurrent malignant ventricular arrhythmias - Therapeutic challenge'. Together they form a unique fingerprint.

Cite this